Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Necrotising soft-tissue infection

Infectious diseases, microbiology and sexual health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Immediate surgical source-control emergency

Rapidly progressive severe pain, systemic toxicity, bullae, anaesthesia, crepitus or shock can indicate fascial necrosis and death within hours.

Action: Use ABCDE, call senior surgery and critical care immediately, obtain cultures without delaying broad intravenous antimicrobials and transfer directly for operative exploration and debridement when clinically suspected.

Synopsis

Recognise necrotising soft-tissue infection before late skin signs, resuscitate toxin-mediated shock and secure immediate operative exploration, debridement and organism-directed therapy.

  • Necrotising soft-tissue infection spreads along fascia, thromboses small vessels and destroys tissue faster than antibiotics can achieve source control.
  • Early skin may look modest; severe escalating pain, oedema beyond erythema and systemic toxicity carry more weight than colour.
  • Do not use a low LRINEC score, normal radiograph or absent gas to rule out disease.
  • First management priority is immediate surgical exploration and excisional debridement; imaging is reserved for uncertainty in a stable patient when it will not delay theatre.
  • Start broad intravenous antibacterial therapy immediately after useful cultures, covering streptococci, staphylococci, Gram-negative organisms and anaerobes according to local policy.
  • Add high-dose clindamycin for suspected streptococcal or clostridial toxin suppression even if laboratory susceptibility to a beta-lactam is expected.
  • Confirmed group A streptococcal disease can be narrowed with microbiology to benzylpenicillin 2.4 g intravenously every four hours plus clindamycin 1.2 g every six hours.
  • Expect serial operations, intensive organ support, nutritional rehabilitation and reconstructive planning rather than a single debridement and short antibiotic course.

Key red flags

Pain out of proportion to visible skin change is an early necrotising-infection warning.

Rapid progression over hours despite antibiotics requires immediate senior surgical reassessment.

Haemorrhagic bullae, dusky skin, anaesthesia or necrosis indicates advanced tissue and nerve injury.

Crepitus or gas on imaging supports gas-forming infection but its absence does not reassure.

Hypotension, confusion, coagulopathy, lactate rise or acute kidney injury signals toxin-mediated shock.

Recent surgery, penetrating trauma, childbirth, injection, immune compromise or water exposure changes organism risk.

Disproportionate escalating pain

Deep severe pain beyond the visible erythematous margin, particularly when rapidly worsening, is an important early feature before skin necrosis develops.

Rapid oedematous spread

Tense swelling extending beyond erythema, woody induration and progression over hours suggest fascial-plane spread rather than routine cellulitis.

Late cutaneous signs

Dusky discoloration, haemorrhagic bullae, skin anaesthesia, necrosis and crepitus indicate microvascular failure and advanced destructive disease.

Toxin-mediated systemic illness

Rigors, vomiting, diarrhoea, confusion, hypotension, coagulopathy and multiorgan dysfunction may dominate the presentation, especially with streptococcal infection.

High-risk portal

Recent surgery, perineal infection, childbirth, injection, penetrating injury, chronic ulcer or seawater and freshwater exposure provides an organism and anatomy clue.

Investigation priorities

01
Immediate senior surgical assessmentFirst step

Determine whether clinical suspicion warrants operative exploration without diagnostic delay.

Management branches

SUSPECTActivate surgery and resuscitation

Disproportionate pain, rapid progression, fascial signs or systemic toxicity creates meaningful suspicion.

  1. Use ABCDE, obtain large-bore access, measure lactate and glucose, send blood cultures and organ-function tests and begin physiology-guided crystalloid resuscitation.
  2. Contact senior surgery, anaesthesia, critical care and microbiology simultaneously and communicate why operative exploration cannot wait for diagnostic certainty.
  3. Start broad intravenous antibacterial therapy plus toxin-suppressing clindamycin according to the local necrotising-infection pathway after cultures when feasible.
  4. Provide strong analgesia, keep the patient fasted, correct major coagulopathy when possible and transfer to theatre without waiting for imaging or a LRINEC score.

Key medicines

Empirical piperacillin–tazobactam, clindamycin and vancomycinWhere the local severe soft-tissue pathway selects it, give piperacillin–tazobactam 4.5 g intravenously every six hours plus clindamycin 1.2 g every six hours and weight- and level-guided intravenous vancomycin.This combination is locally dependent; clarify beta-lactam allergy, calculate renal function and dosing weight, monitor vancomycin levels and kidney injury, and adjust promptly using deep cultures.
Benzylpenicillin plus clindamycin for confirmed GASGive benzylpenicillin 2.4 g intravenously every four hours plus clindamycin 1.2 g intravenously every six hours after microbiology confirms susceptible group A Streptococcus.Check immediate penicillin allergy, renal and hepatic function and clindamycin-associated diarrhoea; continue surgical source control because antimicrobial activity cannot rescue necrotic tissue.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG253 Suspected sepsis in people aged 16 or over
  • NHS Necrotising fasciitis information
  • Invasive group A streptococcal disease: managing community contacts
  • NICE BNF Clindamycin drug monograph

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Apparently normal early skin

Severe pain and physiological decline with limited surface change should increase rather than reduce concern because fascial disease begins deep.